Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
about
Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic optionsAssessing lead time of selected ovarian cancer biomarkers: a nested case-control studyAberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancerCA125 in ovarian cancerMolecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patientsImmunoassays for the cancer biomarker CA125 based on a large-birefringence nematic liquid-crystal mixtureOver-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer PatientsPrognostic values of normal preoperative serum cancer markers for gastric cancer.Diagnostic values of carcinoembryonic antigen in predicting peritoneal recurrence after curative resection of gastric cancer: a meta-analysis.Serum carbohydrate antigen 125 concentration as a superior predictor for serosal effusion at diagnosis and a prognostic factor in diffuse large B-cell lymphoma.Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.Developing a deeper insight into reproductive biomarkers.The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?Circulating methylated MINT2 promoter DNA is a potential poor prognostic factor in gastric cancer.
P2860
Q26748666-6D6A97B2-E776-47C0-9CAA-8CA234415FFAQ33574039-E12E161E-B25A-494C-A437-C9DC5F4199E0Q33596504-1259D21D-6CFB-46F4-9C34-D878C9CB06F7Q33859857-83599620-DB0D-48D6-A47C-1B8E14051A17Q34750564-B0D1EC52-E26D-482D-B04F-D6EEBB6677EBQ35049258-EA616D81-42CC-460F-A297-4533D0237B82Q36654661-4D9A824B-4A04-4E26-A08C-440ECBB45A44Q37629042-38EC1B55-9A02-40C2-AA7E-59BDD72AD2FAQ38174806-2E17B380-2B24-47BA-8C44-F892C7F07353Q40643740-42C112F8-56F1-4B52-9B1D-6475BF73AB71Q43799326-973C9B50-C8CE-4387-AC09-4FC41542DB1AQ47124055-003650DE-DA05-40C9-97F6-FAA93D9529CCQ49627412-EA5B6320-103E-4AA5-8864-A1871B9B9F27Q50882005-305A8C2A-5B99-48D1-B837-E1C4515F85B5Q53078952-658DC675-D87D-483F-ACCE-D0B04F19CD71Q55057577-42CED9B1-036D-4327-9FFD-472E3C47F8C0
P2860
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@ast
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@en
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@nl
type
label
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@ast
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@en
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@nl
prefLabel
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@ast
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@en
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@nl
P2093
P1476
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients.
@en
P2093
Hideo Baba
Manabu Yamamoto
Takeshi Okamura
Yasushi Toh
P2888
P304
P356
10.1007/S00432-006-0189-2
P577
2007-01-17T00:00:00Z